Cheng‐Lung Ku

14.0k total citations
42 papers, 1.7k citations indexed

About

Cheng‐Lung Ku is a scholar working on Immunology, Epidemiology and Cancer Research. According to data from OpenAlex, Cheng‐Lung Ku has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 14 papers in Epidemiology and 12 papers in Cancer Research. Recurrent topics in Cheng‐Lung Ku's work include NF-κB Signaling Pathways (12 papers), Immunodeficiency and Autoimmune Disorders (11 papers) and Immune Response and Inflammation (10 papers). Cheng‐Lung Ku is often cited by papers focused on NF-κB Signaling Pathways (12 papers), Immunodeficiency and Autoimmune Disorders (11 papers) and Immune Response and Inflammation (10 papers). Cheng‐Lung Ku collaborates with scholars based in Taiwan, France and United States. Cheng‐Lung Ku's co-authors include Jean‐Laurent Casanova, Capucine Pïcard, Anne Puel, Jacinta Bustamante, Horst von Bernuth, Asma Smahi, Rainer Döffinger, Jing-Ya Ding, Kun Yang and Han-Po Shih and has published in prestigious journals such as Nature Medicine, Blood and The Journal of Immunology.

In The Last Decade

Cheng‐Lung Ku

42 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng‐Lung Ku Taiwan 23 1.0k 614 339 241 212 42 1.7k
Weitao Huang United States 13 2.0k 2.0× 492 0.8× 404 1.2× 286 1.2× 86 0.4× 16 2.7k
Thomas Marth Germany 28 1.2k 1.2× 536 0.9× 163 0.5× 269 1.1× 86 0.4× 52 3.4k
Siva Kanangat United States 18 968 1.0× 701 1.1× 133 0.4× 319 1.3× 111 0.5× 26 1.8k
Orchidée Filipe‐Santos France 13 950 0.9× 550 0.9× 364 1.1× 125 0.5× 60 0.3× 16 1.2k
J McNicholl United States 14 670 0.7× 340 0.6× 147 0.4× 229 1.0× 112 0.5× 22 1.6k
Ikuya Tsuge Japan 24 1.6k 1.6× 458 0.7× 389 1.1× 290 1.2× 74 0.3× 87 3.0k
Güzide Aksu Türkiye 20 1.1k 1.1× 325 0.5× 165 0.5× 320 1.3× 44 0.2× 124 1.7k
Joyce Eskdale United Kingdom 26 1.8k 1.8× 494 0.8× 135 0.4× 452 1.9× 127 0.6× 46 3.0k
Nancy H. Augustine United States 24 630 0.6× 292 0.5× 169 0.5× 182 0.8× 102 0.5× 42 1.3k
Ana E. Sousa Portugal 28 2.0k 1.9× 437 0.7× 471 1.4× 351 1.5× 62 0.3× 87 2.8k

Countries citing papers authored by Cheng‐Lung Ku

Since Specialization
Citations

This map shows the geographic impact of Cheng‐Lung Ku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Lung Ku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Lung Ku more than expected).

Fields of papers citing papers by Cheng‐Lung Ku

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Lung Ku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Lung Ku. The network helps show where Cheng‐Lung Ku may publish in the future.

Co-authorship network of co-authors of Cheng‐Lung Ku

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Lung Ku. A scholar is included among the top collaborators of Cheng‐Lung Ku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Lung Ku. Cheng‐Lung Ku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ku, Cheng‐Lung, et al.. (2023). Anti-IL-17A antibody-associated de novo vitiligo: Case report and review of literature. Frontiers in Immunology. 13. 1077681–1077681. 9 indexed citations
2.
Ng, Chau Yee, et al.. (2023). Targeting the elevated IFN-γ in vitiligo patients by human anti- IFN-γ monoclonal antibody hampers direct cytotoxicity in melanocyte. Journal of Dermatological Science. 110(3). 78–88. 14 indexed citations
3.
Chen, Yi‐Chun, Shao‐Wen Weng, Jing-Ya Ding, et al.. (2022). Clinicopathological Manifestations and Immune Phenotypes in Adult-Onset Immunodeficiency with Anti-interferon-γ Autoantibodies. Journal of Clinical Immunology. 42(3). 672–683. 12 indexed citations
4.
Kuo, Chen-Yen, Cheng‐Lung Ku, Shao‐Hsuan Hsia, et al.. (2022). Life-Threatening Enterovirus 71 Encephalitis in Unrelated Children with Autosomal Dominant TLR3 Deficiency. Journal of Clinical Immunology. 42(3). 606–617. 6 indexed citations
5.
6.
Lin, Yu‐Jr, et al.. (2021). Feasibility of oral tranexamic acid for vitiligo patients with melasma. Dermatologic Therapy. 34(5). e15047–e15047. 5 indexed citations
7.
Tu, Kun‐Hua, Tai‐Di Chen, Wen‐Yu Chuang, et al.. (2021). TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities. International Journal of Molecular Sciences. 22(12). 6286–6286. 6 indexed citations
8.
Shih, Han-Po, et al.. (2021). Anti-interferon-γ autoantibody-associated immunodeficiency. Current Opinion in Immunology. 72. 206–214. 43 indexed citations
9.
Ku, Cheng‐Lung, et al.. (2020). Autoantibodies against cytokines: phenocopies of primary immunodeficiencies?. Human Genetics. 139(6-7). 783–794. 59 indexed citations
10.
Ding, Jing-Ya, et al.. (2019). Disseminated Mycobacterium avium complex infection mimicking malignancy in a patient with anti-IFN-γ autoantibodies: a case report. BMC Infectious Diseases. 19(1). 909–909. 9 indexed citations
11.
Liu, Shou-Hsuan, Chao‐Yu Chen, Yi‐Jung Li, et al.. (2017). The value of time-averaged serum high-sensitivity C-reactive protein in prediction of mortality and dropout in peritoneal dialysis patients. Therapeutics and Clinical Risk Management. Volume 13. 1009–1021. 10 indexed citations
12.
Chang, Ming‐Ling, Kung‐Hao Liang, Cheng‐Lung Ku, et al.. (2016). Resistin reinforces interferon λ-3 to eliminate hepatitis C virus with fine-tuning from RETN single-nucleotide polymorphisms. Scientific Reports. 6(1). 30799–30799. 23 indexed citations
13.
Ku, Cheng‐Lung, et al.. (2013). Successful Unrelated Cord Blood Stem Cell Transplantation in an X-linked Chronic Granulomatous Disease Patient with Disseminated BCG-induced Infection. Pediatrics & Neonatology. 56(5). 346–350. 10 indexed citations
14.
15.
Mahlaoui, Nizar, Véronique Minard‐Colin, Capucine Pïcard, et al.. (2010). Isolated Congenital Asplenia: A French Nationwide Retrospective Survey of 20 Cases. The Journal of Pediatrics. 158(1). 142–148.e1. 36 indexed citations
16.
Bernuth, Horst von, Anne Puel, Cheng‐Lung Ku, et al.. (2006). Autosomal recessive Interleukin-1 receptor-associated kinase 4 deficiency in fourth-degree relatives. The Journal of Pediatrics. 148(4). 549–551. 35 indexed citations
17.
Ku, Cheng‐Lung, Kun Yang, Jacinta Bustamante, et al.. (2005). Inherited disorders of human Toll‐like receptor signaling: immunological implications. Immunological Reviews. 203(1). 10–20. 94 indexed citations
18.
Lawrence, Tatiana, Anne Puel, Janine Reichenbach, et al.. (2004). Autosomal-dominant primary immunodeficiencies. Current Opinion in Hematology. 12(1). 22–30. 17 indexed citations
19.
Feinberg, Jacqueline, Claire Fieschi, Rainer Döffinger, et al.. (2004). Bacillus Calmette Guérin triggers the IL‐12/IFN‐γ axis by an IRAK‐4‐ and NEMO‐dependent, non‐cognate interaction between monocytes, NK, and T lymphocytes. European Journal of Immunology. 34(11). 3276–3284. 100 indexed citations
20.
Puel, Anne, Capucine Pïcard, Cheng‐Lung Ku, Asma Smahi, & Jean‐Laurent Casanova. (2003). Inherited disorders of NF-κB-mediated immunity in man. Current Opinion in Immunology. 16(1). 34–41. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weitao Huang Breakdown of academic impact, for papers by Thomas Marth Breakdown of academic impact, for papers by Siva Kanangat Breakdown of academic impact, for papers by Orchidée Filipe‐Santos Breakdown of academic impact, for papers by J McNicholl Breakdown of academic impact, for papers by Ikuya Tsuge Breakdown of academic impact, for papers by Güzide Aksu Breakdown of academic impact, for papers by Joyce Eskdale Breakdown of academic impact, for papers by Nancy H. Augustine Breakdown of academic impact, for papers by Ana E. Sousa
Rankless by CCL
2026